Showing results (1-10 of 635) with videos related to
Sort By:
Pageof 64
Fortschritte Der Neurologie-Psychiatrie|April 6, 2018
[ICD-11: Neurocognitive Disorders]Frank Jessen, Lutz FrölichScientific Reports|July 9, 2026
Attitudes of specialist memory-clinic patients with early symptomatic Alzheimer's disease towards lecanemab: results from a multicenter survey in EuropeJonathan Vöglein, Johannes Levin, Elisabeth Stögmann, et al.Journal of Alzheimer'S Disease : JAD|August 1, 2022
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium SurveyCamilla Caprioglio, Valentina Garibotto, Frank Jessen, et al.Psychiatry Research. Neuroimaging|September 13, 2020
Alzheimer's disease - the 'microbial hypothesis' from a clinical and neuroimaging perspectiveLutz FrölichMethods in Molecular Biology (Clifton, N.J.)|March 1, 2024
Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World SettingsRobert Perneczky, Niels Hansen, Anna Hofmann, et al.Journal of Alzheimer'S Disease : JAD|April 24, 2009
Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trialsDaniel Kopf, Lutz FrölichDer Nervenarzt|November 4, 2021
[Disease-modifying treatment approaches for Alzheimer's disease]Lutz Frölich, Lucrezia HausnerDeutsche Medizinische Wochenschrift (1946)|February 1, 2019
[Antidementia Drug Therapy of Alzheimer's Dementia: Status 2018 and Outlook]Lucrezia Hausner, Lutz FrölichExpert Review of Neurotherapeutics|August 12, 2025
Donanemab for Alzheimer's disease: from preclinical research to the clinical applicationRichard Dodel, Lutz FrölichJournal of Neural Transmission (Vienna, Austria : 1996)|February 13, 2015
The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapyKatrin Morgen, Lutz FrölichPageof 64